ALIMTA + Oxaliplatin
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Colorectal Cancer
Conditions
Colorectal Cancer
Trial Timeline
— → —
NCT ID
NCT00034619About ALIMTA + Oxaliplatin
ALIMTA + Oxaliplatin is a phase 2 stage product being developed by Eli Lilly for Colorectal Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT00034619. Target conditions include Colorectal Cancer.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00034619 | Phase 2 | Completed |
Competing Products
20 competing products in Colorectal Cancer